Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
08/2005
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652768A 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replaceme
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1651422A Production technology of vitamine C-phosphate
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/09/2005US6927306 Process for producing hydrogenated aromatic polycarboxylic acid and process for producing hydrogenated aromatic polycarboxylic anhydride
08/09/2005US6927300 Process for the preparation of Latanoprost
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/09/2005CA2164690C Method for safening herbicides in cereal crops using 5-aryloxy-1, 2-(disubstituted)benzene compounds
08/04/2005WO2005070916A1 Thiophene and furan compounds
08/04/2005WO2005070914A1 A method for the preparation of citalopram acid addition salts
08/04/2005WO2005070913A1 Thermally modulated antioxidants
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070865A1 Method of preparing monoesters of polyhydroxyl alcohols
08/04/2005WO2005070405A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
08/04/2005WO2005069981A2 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide
08/04/2005WO2005058853A3 Method for the production of defined mixtures of thf, bdo and gbl by gas phase hydrogenation
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171356 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171208 Histone deacetylase inhibitors
08/04/2005US20050171196 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
08/04/2005US20050171190 Substituted 5-chroman-5-YL-ethylamine compounds and their use for the treatment of glaucoma
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171184 Resolution with acid; salt formation, cyclization
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/04/2005US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders
08/04/2005US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma
08/04/2005CA2554619A1 Method of preparing monoesters of polyhydroxyl alcohols
08/04/2005CA2554119A1 Thermally modulated antioxidants
08/04/2005CA2554047A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
08/04/2005CA2551769A1 Aqueous polymer dispersions containing alkenyl succinic acid anhydrides, methods for the production thereof, and use of the same
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558597A2 Continuous process for the production of optically pure (s)-beta hydroxy-gamma-butyrolactone
08/03/2005EP1558572A2 Novel compounds and their use as prar-modulators
08/03/2005EP1558571A1 Novel compounds useful in treating ppar mediated diseases
08/03/2005EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
08/03/2005EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005EP1154853B1 High surface area sol-gel route prepared hydrogenation catalysts
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649860A Manufacture of ketopantolactone
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649826A 5-amino-1-pentene-3-ol substituted derivatives
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649809A Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649579A N-acylaminoacetonitrile derivatives and their use for controlling parasites
08/03/2005CN1213341C Colour photographic material
08/03/2005CN1213043C Preparation method for cnidium fruit
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213019C Sulfonamide and carboxamide derivatives and drugs containing same as active ingredient
08/03/2005CN1213018C Liquid crystal compounds
08/02/2005US6924396 α-haloenamine reagents
08/02/2005US6924386 Enantioselective reformatsky process for preparing optically active alcohols, amines and derivatives thereof
08/02/2005US6924312 Taxol enhancer compounds
08/02/2005US6924286 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068415A1 Phenylalanine derivative
07/28/2005WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses
07/28/2005US20050165244 precipitating the citalopram base in crystalline form, and transforming the base into a pharmaceutically acceptable citalopram salt; useful for removing intermediates which are structurally closely related to citalopram
07/28/2005US20050165243 Process for the production of an immunosuppressant
07/28/2005US20050165092 Crystalline base of citalopram
07/28/2005US20050165066 Antiproliferative agents
07/28/2005US20050165045 Compounds and methods
07/28/2005US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders
07/28/2005US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/28/2005US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005US20050164869 Practical chiral zirconium catalyst
07/28/2005DE10361457A1 Neue Alkoxylactone, Alkoxylactame und Alkoxythiolactame New Alkoxylactone, alkoxylactams and Alkoxythiolactame
07/28/2005DE10206849A1 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben Phenalenone derivatives, to processes for preparing and using the same
07/27/2005EP1557166A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
07/27/2005EP1556376A1 Large conductance calcium-activated k channel opener
07/27/2005EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
07/27/2005EP1556335A1 Bis-alkylbenzylamines
07/27/2005EP1470117B1 Methylenelactone synthesis in supercritical fluids
07/27/2005EP1428812B1 Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives
07/27/2005EP1131674B1 Colour photographic material
07/27/2005CN1646518A 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
07/27/2005CN1646515A Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
07/27/2005CN1646514A Method for producing gamma-butyrolactone
07/27/2005CN1646513A An antimicrobial agent
07/27/2005CN1646478A 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds